CD8A and COVID-19: Although this implication requires direct confirmation of reduced CD73 expression in COVID-19 patients with AKI and although it is unknown which tissues/cells lack sufficient CD73 in COVID-19 patients with AKI, it is notable that CD73 expression on CD8 + T, natural killer T and natural killer cells is reduced in patients with COVID-1935.